Adenocarcinoma of Colon Terminated Phase 2 Trials for Irinotecan (DB00762)

Also known as: Adenocarcinoma Colon / Colon Adenocarcinoma / Adenocarcinoma of the Colon

IndicationStatusPhase
DBCOND0060083 (Adenocarcinoma of Colon)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00052585
Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal CancerTreatment